Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid

Molecular Human Reproduction

Volumn 12, Issue 8, 2006, Pages 497-503

  Pilka, R ^a,b   Noskova, V ^a   Domanski, H ^a   Andersson, C ^a   Hansson, S ^a   Casslén, Bertil ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Implantation; MMP 26; mRNA; Protein; Uptake

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADULT; ARTICLE; CELL GRANULE; CONTROLLED STUDY; EMBRYO; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MENSTRUAL CYCLE; NIDATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SECRETORY CELL; STROMA CELL; UTERUS FLUID; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; EMBRYO IMPLANTATION; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES; UTERUS;

EID: 33747894503     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal055     Document Type: Article

References (64)

1. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435,39-44.
2. Apte SS, Olsen BR and Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270,14313-14318.
3. Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R and Piao YS (2005) Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Reproduction 129,103-113.
4. Behrendtsen O, Alexander CM and Werb Z (1992) Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114,447-456.
5. Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD and Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61,3610-3618.
6. Bischof P, Friedli E, Martelli M and Campana A (1991) Expression of extracellular matrix-degrading metalloproteinases by cultured human cytotrophoblast cells: Effects of cell adhesion and immunopurification. Am J Obstet Gynecol 165,1791-1801.
7. Brenner CA, Adler RR, Rappolee DA, Pedersen RA and Werb Z (1989) Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev 3,848-859.
8. Brew K, Dinakarpandian D and Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477,267-283.
9. Casslen B (1986) Uterine fluid volume. Cyclic variations and possible extrauterine contributions. J Reprod Med 31,506-510.
10. Casslen BG (1987) Free amino acids in human uterine fluid. Possible role of high taurine concentration. J Reprod Med 32,181-184.
11. Casslen B and Astedt B (1981) Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 60,55-58.
12. Casslen B and Ohlsson K (1981) Cyclic variation of proteinase inhibitors in human uterine fluid and influence of an IUD. Contraception 23,425-434.
13. Casslen B and Nilsson B (1984) Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea. Am J Obstet Gynecol 150,877-881.
14. Casslen B, Thorell J and Astedt B (1981) Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid. Contraception 23,435-445.
15. Casslen B, Kobayashi TK and Stormby N (1982) Cyclic variation of the cellular components in human uterine fluid. J Reprod Fertil 66,213-218.
16. Casslen B, Nordengren J, Gustavsson B, Nilbert M and Lund LR (1995) Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. J Clin Endocrinol Metab 80,2776-2784.
17. Chegini N, Rhoton-Vlasak A and Williams RS (2003) Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril 80,564-570.
18. de Coignac AB, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy JY and Gauchat JF (2000) Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem 267,3323-3329.
19. Cox KH, DeLeon DV, Angerer LM and Angerer RC (1984) Detection of mRNA in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101,485-502.
20. Douglas DA, Shi YE and Sang QA (1997) Computational sequence analysis of the tissue inhibitor of metalloproteinase family. J Protein Chem 16,237-255.
21. Egeblad M and Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2,161-174.
22. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J and Damsky CH (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol 109,891-902.
23. Goffin F, Munaut C, Frankenne F, Perrier D'Hauterive S, Beliard A, Fridman V, Nervo P, Colige A and Foidart JM (2003) Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 69,976-984.
24. Graham CH and Lala PK (1992) Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol 70,867-874.
25. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271,30375-30380.
26. Hampton AL and Salamonsen LA (1994) Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 141,R1-R3.
27. Hendrickson MR and Kempson RL (1980) Surgical Pathology of the Uterine Corpus. Saunders, Philadelphia.
28. Hernandez-Barrantes S, Bernardo M, Toth M and Fridman R (2002) Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 12,131-138.
29. Inagaki N, Stern C, McBain J, Lopata A, Kornman L and Wilkinson D (2003) Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum Reprod 18,608-615.
30. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH and Fisher SJ (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 113,437-449.
31. Licht P, Losch A, Dittrich R, Neuwinger J, Siebzehnrubl E and Wildt L (1998) Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update 4,532-538.
32. Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA and Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J Biol Chem 272,20479-20483.
33. MacLaughlin DT and Richardson GS (1983) Analysis of human uterine luminal fluid proteins following radiolabeling by reductive methylation: comparison of proliferative and secretory phase samples. Biol Reprod 29,733-742.
34. Marbaix E, Kokorine I, Moulin P, Donnez J, Eeckhout Y and Courtoy PJ (1996) Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci USA 93,9120-9125.
35. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI and Strongin AY (2001) Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 356,705-718.
36. Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Hoyer-Hansen G, Hansson SR and Casslen B (2004) Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 10,655-663.
37. Noyes RW, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
38. O'Sullivan CM, Ungarian JL, Singh K, Liu S, Hance J and Rancourt DE (2004) Uterine secretion of ISP1 & 2 tryptases is regulated by progesterone and estrogen during pregnancy and the endometrial cycle. Mol Reprod Dev 69,252-259.
39. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE and Sang QX (2000) Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 275,20540-20544.
40. Pilka R, Whatling C, Domanski H, Hansson S, Eriksson P and Casslen B (2003) Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Mol Hum Reprod 9,271-277.
41. Pilka R, Domanski H, Hansson S, Eriksson P and Casslen B (2004a) Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 10,641-650.
42. Pilka R, Norata GD, Domanski H, Andersson C, Hansson S, Eriksson P and Casslen B (2004b) Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. Gynecol Oncol 94,661-670.
43. von Rango U, Classen-Linke I, Krusche CA and Beier HM (1998) The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 13,3177-3189.
44. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F and Osteen KG (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94,946-953.
45. Rotello RJ, Lieberman RC, Purchio AF and Gerschenson LE (1991) Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88,3412-3415.
46. Salamonsen LA (1999) Role of proteases in implantation. Rev Reprod 4,11-22.
47. Salamonsen LA, Zhang J and Brasted M (2002) Leukocyte networks and human endometrial remodelling. J Reprod Immunol 57,95-108.
48. Shi SR, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39,741-748.
49. Shimonovitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T and Yagel S (1994) Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: A possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol 171,832-838.
50. Stetler-Stevenson WG, Krutzsch HC and Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264,17374-17378.
51. Stracke JO, Hutton M, Stewart M, Pendas AM, Smith B, Lopez-Otin C, Murphy G and Knauper V (2000) Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 275,14809-14816.
52. Tunuguntla R, Ripley D, Sang QX and Chegini N (2003) Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89,453-459.
53. Uria JA and Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 60,4745-4751.
54. Wang H, Wen Y, Mooney S, Li H, Behr B and Polan ML (2003) Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos. Fertil Steril 80(Suppl 2),736-742.
55. Welgus HG and Stricklin GP (1983) Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 258,12259-12264.
56. Whitfield HJ, Brady LS, Smith MA, Mamalaki E, Fox RJ and Herkenham M (1990) Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol. Cell Mol Neurobiol 10,145-157.
57. Woessner JF and Nagase H (2000) Introdution to the matrix metalloproteinases (MMPs). In Woessner JF and Nagase H (eds) Matrix Metalloproteinases and TIMPs. Oxford University Press, New York, pp. 1-10.
58. Young WS (1990) In situ hybridization histochemistry. In Björklund A, Hökfelt T, Wouterlood FG and van den Pol AN (eds) Handbook of Chemical Neuroanatomy: Analysis of Neuronal Microcircuits and Synaptic Interactions. Elsevier Science Publishers B.V., Amste rdam, pp. 481-512.
59. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM and Edwards DR (2002) Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364,89-99.
60. Zhang J and Salamonsen LA (1997) Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 3,735-741.
61. Zhang J, Hampton AL, Nie G and Salamonsen LA (2000) Progesterone inhibits activation of latent matrix metalloproteinase (MMP) -2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium. Biol Reprod 62,85-94.
62. Zhang J, Cao YJ, Zhao YG, Sang QX and Duan EK (2002) Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod 8,659-666.
63. Zhang J, Zhao YG, Cao YJ, Sang QX and Duan EK (2003) Expression and implications of tissue inhibitor of metalloproteinases-4 in mouse embryo. Mol Hum Reprod 9,143-149.
64. Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J and Sang QX (2003) Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 278,15056-15064.